EP3793606
METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF T CELL REDIRECTING THERAPEUTICS
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
15.5.2019EP published:
29.4.2026EP application number:
19803950.5
EPO information:
European Patent Register
Max expiry date:
14.5.2039Expiry date:
28.8.2026
Title in English:
METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF T CELL REDIRECTING THERAPEUTICSLanguage of the patent:
English
Timeline
Today
15.5.2019EP application
29.4.2026EP Publication
28.8.2026Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, Horsham, PA 19044, US
Name:
Stichting Amsterdam UMCAddress:
De Boelelaan 1117, 1081 HV Amsterdam, NL
Inventor
Name:
ADAMS, HomerAddress:
Quakertown, Pennsylvania 18951, US
Name:
GAUDET, FrancoisAddress:
Spring House, Pennsylvania 19477, US
Name:
FRERICHS, KrisAddress:
1081 HV Amsterdam, NL
Name:
VAN DE DONK, NielsAddress:
1081 HV Amsterdam, NL
Name:
VERKLEIJ, Christie C.P.M.Address:
1081 HV Amsterdam, NL
Priority
Number:
201862672222 PDate:
16.5.2018Country:
US
Number:
201862736804 PDate:
26.9.2018Country:
US
Number:
201962842080 PDate:
2.5.2019Country:
US
Classification
Categories:
A61K 39/395, A61K 45/06, C07K 16/28, C07K 16/30, A61K 31/454, A61K 31/69, A61K 39/00